TAKE LIMITED Stock

TAKE

INE142I01023

Biotechnology & Medical Research

Delayed NSE India S.E. 23:59:30 2026-08-16 EDT			5-day change	1st Jan Change
23.95 ^INR	+0.80%		+4.13%	-40.06%

08-11	TAKE LIMITED Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06-25	TAKE SOLUTIONS LIMITED has Changed its Name to TAKE LIMITED	CI

Take Solutions Limited is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
26-08-16	₹23.95	+0.80%	10,430
26-08-14	₹23.76	+0.21%	1,451,037
26-08-13	₹23.71	+0.72%	1,611,067
26-08-12	₹23.54	+1.25%	1,578,857
26-08-11	₹23.25	+1.13%	1,330,458

Delayed Quote NSE India S.E.

More quotes

Income Statement and Estimates

More financial data

Stock Market
Stocks
TAKE Stock

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	5.86B 61.29M 52.94M 49.75M 45.24M 85.06M 86.46M 583M 228M 2.94B 230M 225M 9.75B	P/E 2024	-2.54x	P/E 2025	2.61x
Enterprise Value	5.83B 60.94M 52.64M 49.46M 44.98M 84.57M 85.97M 580M 227M 2.92B 229M 224M 9.7B	EV / Sales 2024	5.18x	EV / Sales 2025	-
Free-Float	40.47%	Yield 2024 *	-	Yield 2025	-

08-11	TAKE LIMITED Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06-25	TAKE SOLUTIONS LIMITED has Changed its Name to TAKE LIMITED	CI
05-20	TAKE LIMITED Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-06	TAKE Solutions Launches INR50 Million Innovation Fund to Support Startups	MT
03-25	Take Solutions launches AI-driven Digital Health platform Take.Health	RE
03-25	Take Solutions Limited Launches Take.Health ? an Intelligent Health Companion Targeting India?s USD 197 Billion Healthcare Opportunity	CI
03-12	TAKE Solutions Sets Up New Wholly Owned Subsidiary; Shares Jump 5%	MT
03-10	TAKE VENTURES PRIVATE LIMITED announced that it has received INR 2.5 million in funding from TAKE Solutions Limited	CI
02-16	Take Solutions to build unified AI platform for healthcare	RE
02-16	TAKE Solutions Limited Announces its Strategic Plan to Develop a Comprehensive Unified AI Platform	CI
02-14	TAKE Solutions Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-11	TAKE Solutions Limited Approves Appointment of Mr. Vilas Munis as Additional Non-Executive Non-Independent Director, Effective February 11, 2026	CI
02-10	Take Solutions Ltd to set up 'One Minute Clinic' in India	RE

17-08-30	TAKE : reports strong Q1 FY18 revenue of INR 3543.71 Mn	PU
17-05-18	TAKE : reports a strong growth of 30.5% in FY17 revenue	PU
17-04-17	TAKE : Augments Executive Management Team	PU
17-02-02	TAKE : Q3 TAKE Solutions reports strong Q3 FY 17 revenue of INR 3,431 Mn	PU
16-11-25	Q2 FY17 Earnings Conference Call on November 03, 2016 at 4:00 PM (IST)	PU

1 day	+0.76%
1 week	+4.13%
Current month	+11.76%
1 month	+25.67%
3 months	-1.56%
6 months	-49.59%
Current year	-40.06%

1 week	22.22	24.39
1 month	18.57	24.39
Current year	18.57	50.14
1 year	9.86	50.14
3 years	6.51	50.14
5 years	6.51	56.1
10 years	6.51	308.25

TAKE LIMITED Stock

Stocks

TAKE

INE142I01023

Biotechnology & Medical Research

Valuation: TAKE LIMITED

Chart: TAKE LIMITED

Latest news : TAKE LIMITED

Press Releases: TAKE LIMITED

Quotes and Performance

Course Extremes

Managers and Directors: TAKE LIMITED

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Vandana Gupta CMP	Compliance Officer	-	2026-01-27
Bala Reddy Latupalli CTO	Chief Tech/Sci/R&D Officer	56	-

Director	Title	Age	Since
Pushpa Joshi BRD	Director/Board Member	-	2025-05-23
Kanwar Nitin Singh BRD	Director/Board Member	43	2025-05-23
Peeyush Sethia BRD	Director/Board Member	47	2025-05-23

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TAKE LIMITED	+0.80%	+4.13%	+139.16%	+31.90%	36.76M
LONZA GROUP AG	-1.78%	-1.68%	+1.48%	+17.26%	48.42B
REVOLUTION MEDICINES, INC.	+0.85%	-0.70%	+460.88%	+581.30%	43.66B
BEONE MEDICINES AG	-2.40%	-0.23%	+8.13%	+80.67%	39.51B
IQVIA HOLDINGS INC.	-2.01%	-0.85%	+23.85%	+9.97%	38.95B
CELLTRION, INC.	-0.50%	+0.85%	+20.60%	+58.18%	32.61B
ASCENDIS PHARMA A/S	+0.38%	-3.23%	-	-	16.32B
MEDPACE HOLDINGS, INC.	-0.59%	-2.06%	+26.35%	+126.36%	16.15B
EUROFINS SCIENTIFIC SE	+0.49%	+0.92%	+4.11%	+26.37%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.43%	+4.70%	+78.74%	+38.66%	13.37B
Average	-0.52%	+0.55%	+84.81%	+107.85%	26.32B
Weighted average by Cap.	-0.91%	-0.11%	+95.83%	+140.25%

	2024	2025
Net sales	656M 6.86M 5.93M 5.57M 5.06M 9.52M 9.68M 65.25M 25.51M 329M 25.76M 25.2M 1.09B	-
Net income	-1.2B -12.51M -10.8M -10.15M -9.23M -17.36M -17.65M -119M -46.51M -599M -46.97M -45.95M -1.99B	375M 3.92M 3.38M 3.18M 2.89M 5.44M 5.53M 37.26M 14.57M 188M 14.71M 14.39M 623M
Net Debt	362M 3.79M 3.27M 3.08M 2.8M 5.26M 5.35M 36.04M 14.09M 181M 14.23M 13.92M 603M	-33.71M -353K -304K -286K -260K -489K -497K -3.35M -1.31M -16.88M -1.32M -1.29M -56.1M